Matthew Margiotta Bio

Matthew joined LifeSci Capital in 2018 as a member of the investment banking team, where he has advised on capital markets and M&A transactions for promising early-stage biotech and medtech, behavioral health, and healthcare technology companies. Prior to joining LifeSci, Matthew spent time at Bank of America Merrill Lynch and UBS in their Global Wealth & Investment Management divisions, with a focus on biotech equity research. Matthew graduated from the University of Michigan and received his B.S. with majors in Mathematics and Statistics.